Purpose: Many patients suffer a stroke at a significant distance from a specialized center capable of delivering endovascular therapy. As a result, they require rapid transport by helicopter emergency medical services, sometimes while receiving a recombinant tissue plasminogen activator infusion (drip and ship). Despite its critical role in the new era of reperfusion, helicopter emergency medical services remains a poorly evaluated aspect of stroke care. Method: Comprehensive narrative review of all published articles of helicopter emergency medical services related to acute stroke care in the inter-hospital and pre-hospital settings, including technical aspects and physical environment implications. Findings: Helicopter emergency medical services transports are conducted during a critical early time period when specific interventions and ancillary care practices may have a significant influence on outcomes. We have limited knowledge of the potential impact of the unusual physical factors generated by the helicopter on the ischemic brain, which affects our ability to establish rational guidelines for ancillary care and the delivery of specific interventions. Discussion: Unlike the pre-hospital and hospital settings where stroke interventions are delivered, the inter-hospital helicopter emergency medical services transfer setting remains a ''black box'' for acute stroke care and research. This gap is particularly relevant for many patients living in rural areas, or in congested urban areas, that depend on helicopter emergency medical services for rapid access to a tertiary stroke center. Conclusion: Addressing the helicopter emergency medical services stroke gap in clinical trials and acute care delivery would homogenize capabilities through all care settings, thus minimizing potential disparities in research access and outcomes based on geographical location.
(HEMS) is an important element in the system for delivering acute stroke care for patients that suffer a stroke at a significant distance from a tertiary stroke center, approximately 20% of the US population, 2, 3 and many other areas of the world. In addition to intravenous recombinant tissue plasminogen activator (rtPA) treatment, endovascular mechanical thrombectomy (MT) recently became the new standard of care in patients with a stroke due to a proximal arterial occlusion. 4 But unlike widely available intravenous rtPA, MT is a complex therapy that requires specific equipment and human expertise only available at a limited number of tertiary centers in the United States. 5 Given the geographic dispersion of the US population, transfer of a great number of patients to an MT-capable center is required. 5 Because MT is a time-dependent therapy tied to viable ischemic penumbra within a short window of opportunity, 4 emergent HEMS is often required. 6 Consequently, HEMS is largely used in the United States for inter-hospital transfer from a community hospital to a comprehensive stroke center, often while receiving rtPA while in route to a tertiary center. 7, 8 It is also used in lesser amount for direct field to hospital operations, mostly in very remote (frontier) or isolated geographical situations, 9, 8 such as islands, sea, 10 or mountains. There are approximately 400,000 total HEMS missions flown a year in the United States. 11 A large 10-year sample of HEMS flights has shown a gradual increase in the ischemic stroke related missions which comprised 4% of the flight missions in 2011. 8 Based on that estimation, there are 16,000 ischemic stroke helicopter missions flown each year in the United States. However, that data might be an underestimation since it preceded the establishment of MT, which requires expeditious transportation. 6, 12 It is therefore expected that the use of HEMS will significantly increase with the widespread implementation of MT. The number of acute stroke-related fixed-wing operations is not known. But given the delays caused by the logistics and since airplane flights require out of hospital take-off and landing, fixed-wing operations are probably not a big additional contributor to acute reperfusion therapy.
Air medical crews are generally composed of flight paramedics and flight nurses, which are sometimes joined by emergency medicine physicians and residents. The procedures to be selected as part of a crew are rigorous, which results in a very skillful yet small number of professionals that cover a large spectrum of patients. 13, 14 As a result, HEMS is staffed by a group of highly trained professionals capable of delivering excellent care during critical early time periods when specific interventions and ancillary care practices may have a significant influence on outcomes.
But despite the obvious and growing relevance of HEMS for acute stroke care, it remains a gap in knowledge and research capabilities ( Figure 1 ).
Inter-hospital HEMS in stroke
The most common (72%) use of HEMS in the United States applies to inter-hospital transfer. 8 It is important to highlight the important differences between the pre-hospital and the inter-hospital settings ( Table 1 ). They occur in two different time periods in acute stroke care since the inter-hospital setting is preceded by care received at a local emergency department (ED) ( Figure 1 ). As a result, there is more cumulative expertise and imaging and laboratory capability in the inter-hospital setting. These patients had been already evaluated at a community hospital and underwent laboratory investigations and a computerized tomography (CT) scan of the brain. 15, 14 In some regional systems, patients are required to be transported to a stroke center to receive rtPA. 16 But the lack of local stroke expertise in these EDs may be compensated by telephonic or telemedicine consultation with a tertiary center, 17 so treatment with rtPA is often initiated locally (''drip & ship''). As a result, patients transported through the inter-hospital setting are a much more selective population than those encountered in the pre-hospital setting 18 . Ischemic stroke mimics, such as intracranial hemorrhage, or hypoglycemia have been typically excluded (Table 1) .
A variety of factors and local regulations play into determining the choice of using HEMS versus ground ambulances for inter-hospital transport. For example, in the United States the Emergency Medical Treatment and Active Labor Act authorize the referring physician to choose the mode of transport. The severity of symptoms, use of rtPA, and need for interventional therapy, as well as system limitations such as distance to the stroke center and availability of critical care air or ground ambulances all play a role. 8, 19 Beside the difference in speed, 16 HEMS-transported patients were receiving higher rates of IV thrombolysis locally 20 as well as more specialized care and interventions. 6 For these reasons, HEMS has been endorsed by the air medical community as the most appropriate method of inter-hospital transportation for acute stroke, 21 a recommendation that preceded the establishment of MT as the new standard of care. This has obviously become even more relevant now since for many patients living in rural areas, or in traffic congested urban areas, HEMS might be the best chance to arrive on time to an MT center. Alternatively, HEMS could be used to transport an interventionalist to treat the patient at hospitals that have the necessary equipment but lack the human expertise.
Still, HEMS has some intrinsic limitations. It is more vulnerable to weather conditions than ground ambulances. Bad weather might result in either not flying at all, or flying at an unjustifiably increased risk. A study showed 182 HEMS crashes in the United States during 1983-2005. 22 While that risk is still relatively low, crashes were more likely to occur in darkness and during instrument-based flying (bad weather). 22 To minimize this issue, flight crews are typically instructed to make their go/no-go decision solely based in operational aeronautical factors. They are deliberately kept blinded to the age and diagnosis of the patient until they are airborne in order to avoid medical/personal biases in their aeronautical decision. 23 Another important limitation is the cost. The use of HEMS for facilitation of intravenous thrombolytic treatment was analyzed regarding cost-effectiveness. A computer model based cost-analysis deemed HEMS to be cost-effective 24 retrospective cohort study raised concerns about the benefit of HEMS unless endovascular therapy is considered. 25 Field to hospital use of HEMS Direct field to stroke center is a pre-hospital HEMS approach that is most appropriate for very remote (frontier) states with little access to stroke-ready hospitals. 9 Local availability of a primary or comprehensive stroke center is of great importance in determining the destination for a HEMS scene transport. This approach was used for 28% of HEMS transports in one large cohort of 25,332 cases. 8 By transporting patients rapidly to a stroke center, it might allow the administration of rtPA 9 or MT. As this is a pre-hospital setting (Table 1) , the patients seen are similar to that encountered by ground emergency medical services (EMS). This includes a combination of ischemic and hemorrhagic strokes, as well as stroke mimics.
There are several differences between ground EMS and HEMS (Table 2 ). Because space is much more limited in air transport, and helicopters cannot easily interrupt their flight in case of unexpected events such as circulation arrest, sudden drop of blood pressure or urination. Patients transported with HEMS need more transport preparation than those transported with ground EMS. Because distances from ground EMS base stations to the scene are usually shorter than outbound distances of HEMS, possible delays to arrival need to be taken into account when decisions are made regarding the mode of transportation. Time savings by HEMS can only be expected in settings with long distances from scene to hospital. An evaluation of inter-hospital transports within a large German TeleStroke network reported a shorter transfer time only when distances between hospitals were longer than 50 km. 26 Advanced pre-hospital stroke work-up and treatment
The new specialized stroke ambulance concept with CT and telemedicine capability 27 aboard ground ambulances allows diagnosis and early treatment before hospital arrival. Studies have shown relevant timeto-treatment reduction in intravenous rtPA application 28, 29 with much higher percentage of patients treated within 60 min from onset, 30 this approach is still rarely used and probably limited to the large metropolitan areas where their cost might be justified by the large volumes. 31 Keeping this in mind, it seems unlikely that CT-carrying stroke ambulances would be implemented in dispersed rural areas with a smaller density of strokes and sometimes limited human expertise (e.g. in the United States typically staffed by voluntary firefighters). 14, 32 HEMS could be an alternative to specialized stroke ambulances for rural areas, allowing the field initiation of rtPA in frontier states. 27, 33 So far, the main limitation for specialized stroke HEMS is the lack of imaging capability. A small study has shown the feasibility of transcranial Doppler (TCD) during HEMS, 34 but this technique requires expertise and is not sufficient to exclude intracranial hemorrhage before initiation of rtPA treatment. An approach similar to the portable CT used by ground ambulances could be considered to increase HEMS capability. 27 There are technical and regulatory barriers to overcome before installing a CT onboard a Medevac helicopter (Table 3 ). Of all the limitations of a helicopter, weight most adversely affects the performance. Other factors that limit helicopter performance are hot ambient temperatures and altitude. This might limit the ability to rescue very heavy patients, or fly longer distances when more fuel is required. Typically, there is little room for extra weight on board most HEMS helicopters. With full fuel, a Eurocopter EC-135 helicopter has a remaining useful load of around 925 kg, which have to be distributed between the four people on board with winter clothing, patient stretcher, survival, monitoring and resuscitation equipment, emergency medical supplies, and additional crew items. This leaves realistically around 200 kg extra at the most, which may accommodate specialized CT scanners that have been lightened for flight. The EC-145 is a slightly larger machine that, when fully fueled, can carry a payload of 1035 kg and therefore would leave a capacity of around 310 kg for a mobile CT scanner. For the significantly larger Bell 412, that available capacity would be 582 kg, making the installation of a portable CT scanner and supporting accessories quite feasible. Larger aircraft such as the Sikorski UH-60M or similar machines would leave around 3500 kg available for installation of a CT scanner. This significant capacity would make the installation quite straightforward but such large helicopters are costly to operate and may not be suitable for smaller landing zones or helipads. There are also issues of radiation isolation in such close quarters, excessive electrical power consumption that may steal mechanical power from the drive train, and electromagnetic interference with the aircraft avionics.
Implications of the HEMS-specific physical environment
Several aspects of HEMS have to be considered for transportation during the critical early period of stroke care. It involves unusual physical factors for stroke patients such as vibration, 35 noise, 36 accelerations, 37 and rapid changes in barometric pressure and partial pressure of oxygen, 38 all of which could potentially affect arterial clot constitution and lysis, reperfusion, and other aspects of neurophysiologic response to ischemic stroke ( Table 4 ). Some of these factors could be potentially harmful for the ischemic brain. For example, the hypobaric environment could worsen the ischemic penumbra, or acceleration in three axes might result in nausea and vomiting that could increase the intracranial pressure and aspiration risk. The extreme noise might result in increased blood pressure and reperfusion injury. In addition, low frequency vibration might increase blood brain barrier permeability, 39 and could potentially affect the efficacy of a rtPA infusion which is supposed not to be shaken after it is reconstituted (Alteplase prescribing information). On the other hand, some of these factors might be beneficial. For example, accelerations and low frequency vibrations 40 might be synergistic with thrombolysis, and thus enhance the therapeutic efficacy of rtPA. Despite these conflicting and potentially significant 36 Blood pressure elevation and reperfusion injury Accelerations 37 Motion sickness, increased intracranial pressure, aspiration pneumonia/pneumonitis Hypobaric changes 38 Worsening of ischemic penumbra rtPA: recombinant tissue plasminogen activator.
factors, the effect of HEMS on an ischemic brain is not known. Retrospective series have suggested no negative net effect, but these studies are naturally limited by selection biases and offer limited sensitivity for changes in outcomes. 25, 41 Randomized controlled studies of an actual helicopter exposure in stroke patients would be difficult due to obvious ethical and logistical concerns. A randomized pilot study on a murine embolic model suggested that helicopter transport did not negatively influence outcomes, and in fact the trend was towards smaller infarctions and hemorrhage. 42 Clearly, the potential influence of HEMS physical factors on stroke outcomes needs to be studied further. It is crucial to understand the net effect and interaction of those physical factors in order to optimize the delivery of thrombolytic agents, best medical care, and eventual neuroprotective agents, for drip and ship stroke patients. 42 
Current ancillary care in patients transported through HEMS
The care of patients transported by HEMS is determined by the physician responsible for the medical oversight of that specific program. 43 In the absence of specific national guidelines, the local rules are typically inspired and adapted from the current guidelines of ground-based stroke management including post-rtPA care. 43 Treatment of patients within the HEMS environment is a combination of standard EMS care as well as ED and ICU level care. Traditional ground ambulance EMS care of stroke patients focuses on early recognition, rapid transport, and early notification to the receiving center. 43 HEMS units transporting patients directly from scene to a hospital typically follow these guidelines as imaging would not have been obtained to rule out hemorrhage. But the HEMS units transporting patients in an inter-hospital capacity are expected to provide care similar to an intensive care unit or an ED, with the obvious limitations of the helicopter capabilities. This includes appropriate blood pressure control, especially in the setting of tPA delivery, airway control, and early identification of complications. While there are ground critical care EMS services that can operate at a similar level to HEMS units, many regions of the country do not have these units available.
They are especially scarce in rural regions. HEMS ancillary-care guidelines are typically based on expert opinion without necessarily taking into consideration the unique physical HEMS environment. 42
Inter-hospital HEMS: An underutilized clinical research opportunity
Pre-hospital HEMS research might be possible with a similar approach as that employed by ambulance based ground trials, 44 with the additional advantage of enhanced human expertise and limited amount of coinvestigators that are needed. However, there is a much greater potential for research in the inter-hospital transfer. It provides a unique opportunity to test specific interventions to preserve the penumbra and mitigate reperfusion injury in transit. 23 Such interventions are particularly relevant for patients with relative access to intravenous (IV) rtPA, but distant from a center that could provide endovascular rescue therapy. Given the time-sensitivity of such interventions, it is important to minimize delays between IV and IA reperfusion treatments. Thus, a HEMS-delivered neuroprotective and reperfusion-mitigating strategy could potentially compensate for this delay, and help mitigate potential differences in outcome based on geographical location. 14 Also, HEMS provides an opportunity to help traditional tertiary-based acute stroke trials by expediting the informed consent process. Patients with stroke transported by HEMS who are incapacitated and unable to provide informed consent typically arrive to the tertiary center well before their relatives who use ground transportation. 13, 23 This temporal patient-surrogate dissociation inevitably results in either delays in enrollment, or ineligibility to enroll at all due to missing the time window. HEMS crews could significantly help this problem by screening and consenting surrogates and, therefore, enrolling subjects at the outside hospital ahead of their arrival to the tertiary institution. 23 The feasibility of HEMS-initiated research approach has been demonstrated in a single-center randomized controlled intervention pilot trial 23 in Iowa that may be generalizable to other academic-based helicopter services. The HEMS personnel from the University of Iowa showed an unanticipated degree of enthusiasm in becoming co-investigators in trials, including completing all the regulatory documents, training, and certification. 23 They also demonstrated an ability to screen patients using simple clinical and laboratory variables that are available at the time patients would be picked up at an outside hospital. 23 That included obtaining an accurate NIH Stroke Scale Score, 23 a finding that was later validated by an independent group. 45 The HEMS crews successfully obtained a signed consent for a low risk vehicle intervention for 52% of the approached subjects. The study also shows that the downtime of the outbound flight to pick up the patient can also be used to potentiate research. If the HEMS crews were successful in talking with the patient or family members about the study using the onboard 800 MHz radiophone before their arrival, the consent rate increased to 69% for a low-risk intravenous intervention. 23 This illustrates the benefit of advance notification about the study for promoting subsequent informed consent in a very time-pressured environment.
Another potential barrier to HEMS-based research, the oversight of institutional research board (IRB), was also addressed. We learned that the transfer of legal care to the tertiary emergency department occurs the moment the University based HEMS team arrives at the outside hospital and meets the patient. 23 Consequently, the University of Iowa IRB determined that research activities could also be initiated at that same time under the umbrella of the University IRB that supervises the emergency department. 23 In rural areas, HEMS services cover a large area with multiple community/critical access hospitals. Involving and certifying each of these institutions as research centers would be logistically problematic, if not impossible. Many of these small hospitals do not even have an IRB. Therefore, university-based IRB agreement is crucial for HEMS-based stroke research in order to ensure adequate subject protection. Because HEMS research is performed by a handful of experienced university-based HEMS crews that serve a large catchment area, it greatly facilitates maintaining their credentials and competence as co-investigators. 23 Based on this preliminary experience, and the accuracy of the diagnosis in this environment, inter-hospital HEMS provides a unique opportunity to test interventions to minimize penumbral expansion and reperfusion injury before arriving to the comprehensive stroke center (CSC). 23 It also provides an opportunity to test specific interventions for intracranial hemorrhages. Given the potential for interaction between the helicopter physical factors and reperfusion and BBB permeability, the ancillary care provided en route and the dosages of neuroprotective interventions might need to be adapted. 42 
Summary/Conclusions
In the era of mechanical reperfusion, HEMS can be a powerful instrument for improving acute stroke delivery and research that is currently underutilized. The speed of HEMS may allow reperfusion for a large number of patients that would not have immediate access due to geography or traffic congestion. Also, HEMS critical early time period after a stroke where specific interventions to preserve penumbra and prevent reperfusion injury may have a significant influence on outcomes. The impact of physical factors generated by the helicopter on the ischemic brain needs to be studied. HEMS are also an opportunity to increase recruitment of patients in standard clinical trials. Addressing the HEMS stroke gap is necessary to homogenize the delivery of acute stroke care and research capabilities through all care settings, therefore minimizing disparities in outcomes based in geographical location.
